References
- 1. Tabish SA. Is Diabetes Becoming the Biggest Epidemic of the Twenty-first Century? Int J Health Sci (Qassim). 2007; 1(2):V-VIII.
- 2. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003; 52(1):102-10.
- 3. Ahrén B. Type 2 diabetes, insulin secretion and betacell mass. Curr Mol Med. 2005; 5(3):275-86
- 4. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008; 88(11):1322-35.
- 5. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010; 33(2):442-9.
- 6. Dokken B. The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids. Diabetes Spectrum 2008; 21(3): 160-165.
- 7. Ali MK, Narayan KM, Tandon N. Diabetes & coronary heart disease: current perspectives. Indian J Med Res. 2010; 132:584-97.
- 8. Tuomilehto T. Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes. Diabetes Care. 2009; 32(Suppl 2): S189–S193.
- 9. Yanai H, Adachi H, Masui Y, Katsuyama H, Kawaguchi A, Hakoshima M et al. Exercise Therapy for Patients With Type 2 Diabetes: A Narrative Review. J Clin Med Res. 2018;10(5):365-369.
- 10. Lee JH, Lee R, Hwang MH, Hamilton MT, Park Y. The effects of exercise on vascular endothelial function in type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2018; 6:10-15.
- 11. Adeghate E, Singh J. Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart Fail Rev. 2014; 19(1):15-23.
- 12. Kharlip J, Naglieri R, Mitchell BD, Ryan KA, Donner TW. Screening for silent coronary heart disease in type 2 diabetes: clinical application of American Diabetes Association guidelines. Diabetes Care. 2006; 29(3):692-4.
- 13. Gheydari ME, Jamali M, Hajsheikholeslami F, Yazdani S, Jamali M. Value of exercise tolerance testing in evaluation of diabetic patients presented with atypical chest discomfort. Int J Endocrinol Metab. 2013; 11(1):11-5.
- 14. Amsterdam EA, Kirk JD, Diercks DB, Turnipseed SD, Lewis WR. Early exercise testing for risk stratification of low-risk patients in chest pain centers. Crit Pathw Cardiol. 2004; 3 (3):114-20.
- 15. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).J Am Coll Cardiol. 1997; 30(1):260-311.
- 16. Hill J, Timmis A. Exercise tolerance testing. BMJ. 2002; 324(7345): 1084–1087.
- 17. Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013; 2013:653789
- 18. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007; 167(11):1145-51.
- 19. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000; 36(2):355-65.
- 20. Melidonis A, Dimopoulos V, Lempidakis E, Hatzissavas J, Kouvaras G, Stefanidis A et al. Angiographic study of coronary artery disease in diabetic patients in com-parison with nondiabetic patients. Angiology. 1999; 50(12):997-1006.
- 21. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004; 27(8):1954-61.
- 22. Karanam A, Kumar BG, Koriginja R. Treadmill test to detect silent myocardial ischemia in asymptomatic type 2 diabetes mellitus. J Assoc Physicians India. 2016; 64(1):77.
- 23. Slavich G, Mapelli P, Fregolent R, Slavich M, Tuniz D. [Non ST ergometric variables in the diabetic patient and their prognostic significance]. Monaldi Arch Chest Dis. 2010; 74(1):28-35.
- 24. Ho PM, Maddox TM, Ross C, Rumsfeld JS, Magid DJ. Impaired chronotropic response to exercise stress testing in patients with diabetes predicts future cardiovascular events. Diabetes Care. 2008; 31(8):1531-3.
- 25. Joshi AS, Lahane CG, Kashid AA. The result of treadmill test in asymptomatic type 2 diabetes mellitus. Int J Sci Rep. 2017; 3(6):166-172.
- 26. Rutter MK, Nesto RW. The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes. Nat Clin Pract Endocrinol Metab. 2007;3(1):26-35
- 27. Makrilakis K, Liatis S. Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros. J Diabetes Res. 2017; 2017:8927473.
- 28. Acampa W, Cantoni V, Green R, Maio F, Daniele S, Nappi C et al. Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: a metaanalysis. J Nucl Cardiol. 2014; 21(5):893-902.